Consequently, future comparisons between eNOS and iNOS should employ drivers of endothelial dysfunction-based hypertension that have similar inhibiting effects on both iNOS and eNOS to encompass the involvement of both agents. This evidence concerns the gene NOS2 and hypertensive disorder.